Unknown

Dataset Information

0

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.


ABSTRACT: The major cause of bacterial resistance to β-lactams is the production of hydrolytic β-lactamase enzymes. Nowadays, the combination of β-lactam antibiotics with β-lactamase inhibitors (BLIs) is the main strategy for overcoming such issues. Nevertheless, particularly challenging β-lactamases, such as OXA-48, pose the need for novel and effective treatments. Herein, we describe the screening of a proprietary compound collection against Klebsiella pneumoniae OXA-48, leading to the identification of several chemotypes, like the 4-ideneamino-4H-1,2,4-triazole (SC_2) and pyrazolo[3,4-b]pyridine (SC_7) cores as potential inhibitors. Importantly, the most potent representative of the latter series (ID2, AC50 = 0.99 μM) inhibited OXA-48 via a reversible and competitive mechanism of action, as demonstrated by biochemical and X-ray studies; furthermore, it slightly improved imipenem's activity in Escherichia coli ATCC BAA-2523 β-lactam resistant strain. Also, ID2 showed good solubility and no sign of toxicity up to the highest tested concentration, resulting in a promising starting point for further optimization programs toward novel and effective non-β-lactam BLIs.

SUBMITTER: Garofalo B 

PROVIDER: S-EPMC8308845 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9258905 | biostudies-literature
| S-EPMC8153228 | biostudies-literature
| S-EPMC7022249 | biostudies-literature
| S-EPMC4068428 | biostudies-literature
| S-EPMC3101449 | biostudies-literature
| S-EPMC6761500 | biostudies-literature
| S-EPMC9097296 | biostudies-literature
| S-EPMC4468662 | biostudies-literature
| S-EPMC6105830 | biostudies-literature
| S-EPMC6153822 | biostudies-literature